Your browser doesn't support javascript.
loading
Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvement.
Oubari, Sara; Naser, Eyad; Papathanasiou, Maria; Luedike, Peter; Hagenacker, Tim; Thimm, Andreas; Rischpler, Christoph; Kessler, Lukas; Kimmich, Christoph; Hegenbart, Ute; Schönland, Stefan; Rassaf, Tienush; Reinhardt, Hans Christian; Jöckel, Karl-Heinz; Dürig, Jan; Dührsen, Ulrich; Carpinteiro, Alexander.
Afiliación
  • Oubari S; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Naser E; Interdisciplinary Amyloidosis Network, University Hospital Essen, Essen, Germany.
  • Papathanasiou M; Institute of Molecular Biology, University of Duisburg-Essen, Essen, Germany.
  • Luedike P; Interdisciplinary Amyloidosis Network, University Hospital Essen, Essen, Germany.
  • Hagenacker T; Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany.
  • Thimm A; Interdisciplinary Amyloidosis Network, University Hospital Essen, Essen, Germany.
  • Rischpler C; Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany.
  • Kessler L; Interdisciplinary Amyloidosis Network, University Hospital Essen, Essen, Germany.
  • Kimmich C; Department of Neurology, University Hospital Essen, Essen, Germany.
  • Hegenbart U; Interdisciplinary Amyloidosis Network, University Hospital Essen, Essen, Germany.
  • Schönland S; Department of Neurology, University Hospital Essen, Essen, Germany.
  • Rassaf T; Interdisciplinary Amyloidosis Network, University Hospital Essen, Essen, Germany.
  • Reinhardt HC; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
  • Jöckel KH; Interdisciplinary Amyloidosis Network, University Hospital Essen, Essen, Germany.
  • Dürig J; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
  • Dührsen U; Department of Hematology and Oncology, Oldenburg Hospital, University Medicine Oldenburg, Oldenburg, Germany.
  • Carpinteiro A; Department of Internal Medicine V, Amyloidosis Center Heidelberg, University Hospital Heidelberg, Heidelberg, Germany.
Eur J Haematol ; 107(4): 449-457, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34185342
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Diagnóstico Tardío / Tiempo de Tratamiento / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Diagnóstico Tardío / Tiempo de Tratamiento / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania